Maumee, OHNCT07905001Now EnrollingIRB Ready

Breast Cancer Clinical Trial in Maumee, OH

Access cutting-edge breast cancer treatment through this phase 1 clinical trial at a research site in Maumee. Study-provided care at no cost to qualified participants.

Sponsored by Prelude Therapeutics Incorporated

Quick Self-Assessment

See if you qualify for this Maumee location

Preparing your pre-screening questions…

Expert Care in Maumee

Access breast cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related breast cancer treatment provided free

Apply for This Maumee Location

Check if you qualify for this breast cancer clinical trial in Maumee, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Maumee

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Maumee site if eligible
  4. 4Begin participation

About This Breast Cancer Study in Maumee

This first-in-human, open-label, multicenter study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of PRT13722, an oral KAT6A protein degrader, in adults with locally advanced or metastatic Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer. PRT13722 will be evaluated as monotherapy and in combination with fulvestrant, abemaciclib plus fulvestrant, or imlunestrant to determine recommended dose(s) for expansion (RDE) and evaluate preliminary clinical activity.

Sponsor: Prelude Therapeutics Incorporated

Who Can Participate

Inclusion Criteria

Willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations (including contraception requirements), and other study procedures.
histological or cytological diagnosis of locally advanced or metastatic HR-positive/HER2-negative breast cancer
Disease progression following prior standard therapy and eligible for the assigned study cohort
Measurable or evaluable disease per RECIST v1.1
Willingness to provide tumor tissue for biomarker analyses
Eastern Cooperative Oncology Group performance status of 0-1
Negative serum or urine pregnancy test and agree to use highly effective contraception or maintain true abstinence.
Adequate organ function and bone marrow reserves (hematology, renal, and hepatic)

Exclusion Criteria

Untreated, symptomatic, or unstable brain metastases
Symptomatic visceral disease at risk of imminent life-threatening complications
Uncontrolled infection or significant concurrent medical conditions
Clinically significant cardiovascular disease or prolonged QT syndrome
Pregnancy or breastfeeding
Prior treatment with a KAT6-targeting agent
Recent anticancer therapy, radiotherapy, or major surgery
Use of prohibited concomitant medications, including strong CYP3A4 inhibitors or inducers, proton pump inhibitors, P-gp inhibitors or inducers, and breast cancer resistance protein inhibitors
Participation in another interventional clinical study
Any condition that would interfere with study participation or evaluation of study results

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Maumee?

Yes, this clinical trial (NCT07905001) has an active research site in Maumee, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Breast Cancer Treatment Options in Maumee, OH

If you're searching for breast cancer treatment options in Maumee, OH, this clinical trial (NCT07905001) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Maumee research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all breast cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Maumee, OH

See all breast cancer clinical trials recruiting in Maumee — not just this study.

Browse Breast Cancer Trials in Maumee →

Ready to Join in Maumee?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Maumee, OH